Gastrointestinal symptoms in kidney transplant recipients: what about silent sufferers?

被引:3
|
作者
van Dijk, Marja [1 ]
Niesing, Jan [1 ]
van der Heide, Jaap J. Homan [1 ]
de Maar, Eltjo F. [1 ]
Ploeg, Rutger J. [1 ]
van Son, Willem J. [1 ]
Seelen, Marc A. J. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands
关键词
QUALITY-OF-LIFE; COATED MYCOPHENOLATE SODIUM; MOFETIL; COMPLICATIONS; CONVERSION;
D O I
10.7182/prtr.20.1.ek7123337w497594
中图分类号
R61 [外科手术学];
学科分类号
摘要
Context-Transplantation improves health-related quality of life in patients with end-stage renal disease. However, primarily because of adverse effects of medication, among other gastrointestinal symptoms, health-related quality of life is not completely restored to normal. Although many patients have various gastrointestinal symptoms only a small proportion may be reported spontaneously. Objective-To evaluate the prevalence of gastrointestinal symptoms in kidney transplant recipients, also the difference between spontaneously reported symptoms and symptoms elicited by specific questioning was assessed. The burden of these symptoms in daily life also was analyzed. Design-A single-center, sequential, mixed method study to assess the difference between spontaneous patient reports of gastrointestinal symptoms and active screening by a questionnaire in kidney transplant patients. Patients-In February 2008, patients received a questionnaire on gastrointestinal symptoms; notes in medical records were consulted for patients scoring less than 100. In June 2008, those patients received a second, extended questionnaire aimed to assess the burden of gastrointestinal symptoms in daily life. Results-Ninety-two of 5 13 patients eventually proved to have gastrointestinal C symptoms. Completed questionnaires were compared with notes in the patients' files of the past year. A total of 51 of these 92 patients appeared to have not mentioned their gastrointestinal symptoms during the outpatient clinic visits. Of these 5 1 patients, 37 reported a significant impact of gastrointestinal symptoms on daily life. Conclusions-The silent sufferer exists. Specific questioning helps to improve communication concerning bothersome gastrointestinal symptoms. To assess the burden of these symptoms, a validated questionnaire should be developed. (Progress in Transplantation. 2010:20:75-80)
引用
收藏
页码:75 / 80
页数:6
相关论文
共 50 条
  • [31] INFLAMMATION IS AN INDEPENDENT PREDICTOR OF DEPRESSIVE SYMPTOMS AND FATIGUE IN STABLE KIDNEY TRANSPLANT RECIPIENTS
    Bosch, J. A.
    Chan, W.
    Phillips, A.
    Jones, D.
    Kaur, O.
    McTernan, P.
    Inston, N.
    Moore, S.
    McClean, A.
    Harper, E.
    Borrows, R.
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2014, 21 : S198 - S198
  • [32] GASTROINTESTINAL BLEEDING (GIB) IN ADVANCED CHRONIC KIDNEY DISEASE AND KIDNEY TRANSPLANT (KT) RECIPIENTS: A NATIONAL ANALYSIS
    He, Mingyue
    Desai, Shaan
    Wang, Yichen
    Gillespie, Avrum
    Friedenberg, Frank
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (04) : S82 - S82
  • [33] Increased prevalence of gastrointestinal symptoms associated with impaired quality of life in renal transplant recipients
    Ekberg, Henrik
    Kyllonen, Lauri
    Madsen, Soren
    Grave, Gisle
    Solbu, Dag
    Holdaas, Hallvard
    TRANSPLANTATION, 2007, 83 (03) : 282 - 289
  • [34] Mycophenolic acid (Myfortic) is an alternative for paediatric renal transplant recipients with gastrointestinal symptoms on mycophenolatemofetil
    Jones, Helen E.
    Walsh, Grainne
    Stojanovic, Jelena
    Thornhill, William
    Taylor, Judy
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1528 - 1529
  • [35] COVID-19 in Kidney Transplant Recipients: What Did We Understand After Three Years Since the Pandemic Outbreak in Kidney Transplant Recipients?
    Angelica Canossi
    Alessandra Panarese
    Valentina Savino
    Tiziana Del Beato
    Francesco Pisani
    Current Transplantation Reports, 2023, 10 : 253 - 260
  • [36] COVID-19 in Kidney Transplant Recipients: What Did We Understand After Three Years Since the Pandemic Outbreak in Kidney Transplant Recipients?
    Canossi, Angelica
    Panarese, Alessandra
    Savino, Valentina
    Del Beato, Tiziana
    Pisani, Francesco
    CURRENT TRANSPLANTATION REPORTS, 2023, 10 (04) : 253 - 260
  • [37] Malignancy in kidney transplant recipients
    Kapoor, Anil
    DRUGS, 2008, 68 (Suppl 1) : 11 - 19
  • [38] Frailty in kidney transplant recipients
    McAdams-DeMarco, Mara
    Ying, Hao
    Olorundare, Israel
    King, Elizabeth
    Segev, Dorry
    TRANSPLANTATION, 2016, 100 (07) : S170 - S170
  • [39] Belatacept for kidney transplant recipients
    Webster, Angela
    NEPHROLOGY, 2015, 20 (10) : 752 - 754
  • [40] Hyperamylasemia in kidney transplant recipients
    Yokoyama, I
    Hayashi, S
    Kobayashi, T
    Negita, M
    Katayama, A
    Nagasaka, R
    Namii, Y
    Kojima, T
    Koike, C
    Uchida, K
    Takagi, H
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (03) : 1476 - 1477